 Primary CNS lymphoma osmotic blood-brain barrier disruption prolonged survival preservation cognitive function Combination chemotherapy radiotherapy modest efficacy treatment primary CNS lymphoma Median survival patients radiotherapy months survival Thirty consecutive non-acquired immune deficiency syndrome patients primary CNS lymphoma barrier-dependent chemotherapy intraarterial mannitol blood-brain barrier BBB Follow-up extensive neuropsychologic testing patients Thirteen patients cranial radiation months referral group Seventeen patients initial BBB disruption chemotherapy subsequent radiation tumor progression recurrence group difference median survivals diagnosis months group months group significant Group survival comparable median survival historical series patients radiotherapy chemotherapy Group patient survival advance survival CNS lymphoma preservation cognitive function complete responders years Patient toxicity manageable intensive therapeutic regimen series plateau survival curves major portion patients neuropsychologic sequelae cranial radiation